Clinical Trial Update: Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 [Phase 2]

View source ↗

Summary

The ARTISTRY-6 Phase 2 trial evaluating nemvaleukin alfa as monotherapy and in combination with pembrolizumab in patients with advanced cutaneous or mucosal mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Mucosal Melanoma

Drugs mentioned

• Nemvaleukin alfa (nemvaleukin alfa)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Mural Oncology, Inc | Conditions: Cutaneous Melanoma, Mucosal Melanoma | Phase 2 | Status: TERMINATED